切换至 "中华医学电子期刊资源库"

中华产科急救电子杂志 ›› 2024, Vol. 13 ›› Issue (04) : 245 -248. doi: 10.3877/cma.j.issn.2095-3259.2024.04.011

所属专题: 经典病例

病例报告

妊娠期新发中重度、活动期Graves眼病一例
卢丹1,2, 贾晓宙2, 张莹3, 王双勇4, 麻希洋1, 贺芳1,()   
  1. 1.广州医科大学附属第三医院妇产科,广州 510150
    2.湖南省妇幼保健院妇产科,长沙 410000
    3.广州医科大学附属第三医院内分泌科,广州 510150
    4.广州医科大学附属第三医院眼科,广州 510150
  • 收稿日期:2023-12-16 出版日期:2024-11-18
  • 通信作者: 贺芳
  • 基金资助:
    产科国家临床重点专科建设(20230414-1001);湖南省2024年产科质量控制中心经费(20240626-1001)

A case of newly diagnosed moderate to severe and active Graves' ophthalmopathy during pregnancy

Dan Lu, Xiaozhou Jia, Ying Zhang, Shuangyong Wang, Xiyang Ma, Fang He()   

  • Received:2023-12-16 Published:2024-11-18
  • Corresponding author: Fang He
引用本文:

卢丹, 贾晓宙, 张莹, 王双勇, 麻希洋, 贺芳. 妊娠期新发中重度、活动期Graves眼病一例[J]. 中华产科急救电子杂志, 2024, 13(04): 245-248.

Dan Lu, Xiaozhou Jia, Ying Zhang, Shuangyong Wang, Xiyang Ma, Fang He. A case of newly diagnosed moderate to severe and active Graves' ophthalmopathy during pregnancy[J]. Chinese Journal of Obstetric Emergency(Electronic Edition), 2024, 13(04): 245-248.

图1 妊娠期新发中重度、活动期Graves眼病患者甲状腺功能变化及用药情况 注:FT4:(free thyroxine)游离甲状腺素;FT3:(free triiodothyronine)游离三碘甲状腺原氨酸;TSH:(thyroid stimulating hormone)促甲状腺素;TRAb:(thyrotropin receptor antibody)促甲状腺素受体抗体
图2 妊娠期新发中重度、活动期Graves眼病患者头颅MRI图像 A、C为2023年7月26日患者孕32+2周头颅MRI横断位图像,B、D为2023年8月8日患者剖宫产术后第1天眼部MRI横断位图像;A与B均为T1W1序列,箭头所示双侧眼内直肌、外直肌肌腹均增粗,相对术前的A图,术后的B图显示眼内直肌肌腹增粗更明显;C与D均为T2W1序列:箭头所示为术前孕32+2周(C图)与剖宫产术后第1天(D图)对比,剖宫产术后第1天出现双眼视神经高亮信号,为视神经水肿 注:MRI:(magnetic resonance imaging)磁共振成像
[1]
Bartalena L,Piantanida E,Gallo D,et al.Epidemiology,natural history,risk factors,and prevention of Graves'orbitopathy[J].Front Endocrinol(Lausanne),2020,11:615993.
[2]
Bartalena L.Diagnosis and management of Graves disease:a global overview[J].Nat Rev Endocrinol,2013,9(12):724-734.
[3]
王曌华,张建平.妊娠合并甲状腺功能亢进症对妊娠结局的影响[J].中国实用妇科与产科杂志,2013,29(6):406-410.
[4]
中华医学会眼科学分会眼整形眼眶病学组,中华医学会内分泌学分会甲状腺学组.中国甲状腺相关眼病诊断和治疗指南(2022年)[J].中华眼科杂志,2022,58(9):646-668.
[5]
《妊娠和产后甲状腺疾病诊治指南》(第2版)编撰委员会,中华医学会内分泌学分会,中华医学会围产医学分会.妊娠和产后甲状腺疾病诊治指南(第2版)[J].中华围产医学杂志,2019,22(8):505-506.
[6]
Lee SY,Pearce EN.Testing,Monitoring,and treatment of thyroid dysfunction in pregnancy[J].J Clin Endocrinol Metab,2021,106(3):883-892.
[7]
Glinoer D.The regulation of thyroid function in pregnancy:pathways of endocrine adaptation from physiology to pathology[J].Endocr Rev,1997,18(3):404-433.
[8]
Yu CY,Ford RL,Wester ST,et al.Update on thyroid eye disease: regional variations in prevalence, diagnosis, and management[J].Indian J Ophthalmol,2022,70(7):2335-2345.
[9]
孙伟杰.胎儿甲状腺疾病的诊断和处理[J/OL].中华产科急救电子杂志,2023,12(4):212-216.
[10]
Bolltl tea RE,Mihai BM,szini E,et al.Diagnosis and management of fetal and neonatal thymtoxicosis[J].Medicina(Kaunas),2022,59(1):36.
[11]
Abalovich M,Amino N,Barbour LA,et al.Management of thyroid dysfunction during pregnancy and postpartum: an endocrine society clinical practice guideline[J].JClin Endocrinol Metab,2007,92(8 Suppl):S1-47.
[12]
Laurberg P,Andersen SL.Endocrinology in pregnancy:pregnancy and the incidence,diagnosing and therapy of Graves'disease[J].Eur J Endocrinol,2016,175(5):R219-230.
[13]
Marx H,Amin P,Lazarus JH.Hyperthyroidism and pregnany[J].BMJ,2008,336(7645):663-667.
[14]
沈铿,马丁.妇产科学[M].3版.北京:人民卫生出版社,2015:196-198.
[15]
甘旭培,徐先明.妊娠合并甲状腺功能亢进的妊娠期监测及治疗[J].实用妇产科杂志,2023,39(5):339-342.
[16]
Bartalena L,Kahaly GJ,Baldeschi L,et al.The 2021 European Group on Graves'Orbitopathy(EUGOGO) clinical practice guidelines for the medical management of Graves'orbitopathy[J].Eur J Endocrinol,2021,185(4):G43-67.
[17]
Ross DS,Burch HB,Cooper DS,et al.2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis[J].Thyroid,2016,26(10):1343-1421.
No related articles found!
阅读次数
全文


摘要